Acyclovir Tablets — Class III drug recall D-0897-2017
Terminated recall by Hetero USA Inc, reported 2017-06-14, distributed nationwide. Presence of Foreign Substance: human hair melded into tablet.
| Recall number | D-0897-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hetero USA Inc, Piscataway, NJ, United States |
| Recall initiated | 2017-04-27 |
| Classified | 2017-06-07 |
| Reported by FDA | 2017-06-14 |
| Terminated | 2017-12-13 |
| Distributed | Nationwide (US) |
| Quantity | 13,692 bottles |
| NDC | 31722-0777, 31722-0777-01, 31722-0777-05, 31722-0778, 31722-0778-01, 31722-0778-05 |
| Lot numbers | ACY16075 |
| Expiration dates | 2018-09 |
Product
Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, by Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-778-01
Reason for recall
Presence of Foreign Substance: human hair melded into tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0897-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.